SOMERVILLE, Mass., December 04, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today announced that it will proceed with a 1-for-20 reverse stock split ("Reverse Stock Split ...

While the market seems to have forgotten about it, several prominent billionaires are piling in. Warren Buffett's company ...

While the artificial intelligence (AI) revolution has been undeniably important in lifting the broader market, it would be ...

DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, ...

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is a tech company focused on building an integrated platform that combines the best technology, intellectual property, and knowledge to solve an ...

Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at ...

CRANFORD, N.J., Nov. 22, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) announced today that it will be executing a reverse stock split of its ...

TransCode Therapeutics (NASDAQ:RNAZ) will execute its previously announced 1-for-33 reverse stock split on Dec. 4, 2024. The company’s common stock is expected to begin trading on a split-adjusted ...

Shares of noco-noco Inc. (NASDAQ:NCNC – Free Report) are set to reverse split before the market opens on Friday, December 20th. The 1-50 reverse split was announced on Thursday, October 17th. The ...

Cemtrex Inc. (NASDAQ: CETX) has recently disclosed a reverse stock split intended to address continued listing requirements on the Nasdaq Capital Market. The decision, approved by the Company’s Board ...

SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares ...

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 /, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while ...